Physician profile
James R Deline
NPI 1679679229
$21,495.79
in general payments reported to CMS, 2019-2025
19 companies · $1,607 in 2025
The $1,607 reported for 2025 was more than what 79% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $240 · 2020: $73.56 · 2021: $3,730 · 2022: $3,712 · 2023: $1,459 · 2024: $11K · 2025: $1,607.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,584 · Education: $4,000 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Travel and Lodging: $1,656 · Consulting Fee: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,584.37 |
| Education | $4,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Travel and Lodging | $1,655.83 |
| Consulting Fee | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $12,422.18 | 2021-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Intuitive Surgical, INC. | $8,163.70 | 2019-2024 | Da Vinci Surgical System |
| Davol INC. | $541.50 | 2019-2024 | Phasix Mesh |
| Medtronic, INC. | $55.55 | 2021 | |
| Conmed Corporation | $33.33 | 2022 | |
| Innovation Technologies INC | $30.31 | 2025 | Irrisept |
| Ethicon US, LLC | $26.41 | 2019 | |
| Becton, Dickinson and Company | $25.62 | 2023 | |
| Allergan, INC. | $22.93 | 2020 | |
| Innocoll Pharmaceuticals Limited | $22.17 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.34 | 2021 | |
| Aroa Biosurgery Incorporated | $21.18 | 2024 | |
| Acell, INC. | $19.99 | 2019 | |
| Teleflex LLC | $19.61 | 2019 | |
| Merck Sharp & Dohme LLC | $18.11 | 2023 | Bridion |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $14.79 | 2020 | |
| Mallinckrodt Hospital Products INC. | $12.92 | 2020 | |
| Optinose US, INC. | $12.31 | 2019 | |
| Boston Scientific Corporation | $11.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Deline listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.